Pfizer Gets OK To Appeal Damages Scope In Lyrica Suit
A judge gave a Pfizer subsidiary a second chance on Thursday to limit the damages it might have to pay for losses caused by threats it made over an epilepsy drug...To view the full article, register now.
Already a subscriber? Click here to view full article